Company Filing History:
2 out of 90 
2 out of 577 
1 out of 203 
Years Active: 2015-2020
Title: The Innovative Contributions of Peter Teriete
Introduction
Peter Teriete is a notable inventor based in La Jolla, California. He has made significant contributions to the field of biomedical research, particularly in the area of HIV therapy. With a total of 3 patents to his name, Teriete's work has the potential to impact the treatment of human immunodeficiency virus (HIV) significantly.
Latest Patents
Among his latest patents, Teriete has developed methods involving the use of inhibitor of apoptosis protein (IAP) antagonists in HIV therapy. His patents detail the use of compounds that modulate the activity of IAPs, either alone or in combination with other therapeutic agents, to treat HIV. This innovative approach aims to provide new avenues for effective treatment in individuals suffering from this virus.
Career Highlights
Throughout his career, Peter Teriete has worked with esteemed institutions such as the Sanford Burnham Prebys Medical Discovery Institute and the Salk Institute for Biological Studies. His research has focused on advancing therapeutic strategies for HIV, showcasing his commitment to improving health outcomes for affected individuals.
Collaborations
Peter has collaborated with notable colleagues, including Lars Pache and Sumit K Chanda. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in HIV treatment.
Conclusion
Peter Teriete's innovative work in the field of HIV therapy exemplifies the impact of dedicated research and collaboration. His contributions continue to pave the way for advancements in medical science and patient care.